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 ABSTRACT: Gels obtained by complexation of octablock star PEO/PPO copolymers 
(Tetronic 90R4) with α-CD were evaluated as matrices for drug release. Both molecules 
are biocompatible so they can be potentially applied to drug delivery systems. Two 
different types of matrices of Tetronic 90R4 and α-CD were evaluated: gels and tablets. 
These gels are capable to gelifying in-situ and show sustained erosion kinetics in 
aqueous media. Tablets were prepared by freeze drying and comprising the gels. Using 
these two different matrices the release of two model molecules, L-Tryptophan (Trp), 
and a protein, bovine serum albumin (BSA), was evaluated. The release profiles of these 
molecules from gels and tablets prove that they are suitable for sustained delivery. 
Mathematical models were applied to the release curves from tablets in order to 
elucidate the drug delivery mechanism. Good correlations were found for the fittings of 
the release curves to different equations. The results point that the release of Trp from 
different tablets is always governed by Fickian diffusion while the release of BSA is 
governed by a combination of diffusion and tablet erosion. 
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Introduction 
Hydrogel matrices have been gaining relevance throughout the years as drug delivery 
systems or even as medical devices.1, 2  This is due mainly to their hydrophilicity, their 
biocompatibility and their drug loading and release promising properties. Hydrogels can 
be loaded with a drug or an active substance and be implanted into a patient enabling a 
controlled drug release. Another type of hydrogels is in situ gelling systems. They 
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possess new promising properties such as a fast degradation process or the capability of 
forming the gel where it is needed by physical crosslinking between different 
molecules. In this process of gelation, a protein, a peptide or a drug can be added to the 
mixture before the crosslinking takes place, so it will finally get immobilised inside the 
bulk of the gel.3-8 This last property is very important because it allows us to inject the 
mixture inside a tissue using a simple needle without any kind of surgery.9, 10 Self-
assembled hydrogels constitute an important family of these in situ gelling systems. 
These kind of hydrogels are supramolecular systems that are formed spontaneously 
when their constituents come into contact or else after a certain trigger such as 
temperature 10. The interest on these materials has grown in recent years. 3, 5-7, 9-11 Self-
assembled hydrogels can be obtained using a large variety of natural or synthetic 
products, and their properties depend strongly on their composition. A group of 
molecules that are extensively used for this purpose are the amphiphilic polymers. 
Amphiphilic polymers have been widely used in drug delivery systems. They 
can form micelles or aggregates that increase the solubility of hydrophobic drugs and 
can be applied as drug delivery systems.12 One of the most common amphiphilic groups 
of molecules is polyethylene oxide/polypropylene oxide (PEO/PPO) block copolymers. 
BASF produces mainly two different types of PEO/PPO block copolymers, 
namely Pluronic (or poloxamers) and Tetronic (or poloxamines). Pluronics are linear 
triblock copolymers with the architecture PEO-PPO-PEO. Tetronic are four arm star-
like copolymers with two blocks per arm. Depending on the distribution of the blocks in 
its arms, the molecule can be a Tetronic (normal) or a Tetronic R (reverse). The former 
have the PEO blocks in the outer part of the arms, while in the latter the PEO blocks are 
the inner ones. 
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PEO/PPO block copolymers can be employed as micellar nanocarriers for drug 
delivery due to their high solubilisation capacity and biocompatibility. These systems 
are not just inert carriers but they can act as biological response modifiers because they 
can induce certain cellular responses, such as inhibition of cell efflux transporters and 
ability to increase drug transport across membranes, which can be advantageous from 
the therapeutic point of view.13-15 As a matter of fact, poloxamines have been 
successfully employed in the preparation of different therapeutic systems, such as 
micellar drug carriers16 and nanoparticles.17,18 In this sense, nanoparticle surface 
modification with poloxamines was found to determine the biological fate of certain 
carrier systems. In addition, these polymers have been applied in the field of injectable 
implants.19 For instance, cytocompatible implantable matrices for sustained release of 
ciprofloxacin have been prepared using poli-ε-caprolactone/poloxamine blends.20 
Some of these amphiphilic copolymers can gelify by themselves in aqueous 
solutions under certain conditions.16-19 The addition of cyclodextrins (CDs) enhances 
the gelation process for PEO/PPO block copolymers, even to the point of making 
feasible the formation of gels with poloxamers or poloxamines that do not gelify by 
themselves.202122 It has been shown that the addition of α-cyclodextrin (α-CD) to PEO-
PPO solutions leads to the formation of inclusion complexes between α-CD and the 
PEO blocks with a polypseudorotaxane structure and the aggregation between 
uncomplexed PPO blocks by hydrophobic interactions, yielding gels.20, 21,9,23
Diverse types of hydrogels based on cyclodextrins have been prepared 
previously.24,25 Nevertheless, those were chemically crosslinked gels, so the in situ 
physical hydrogels formed with CD and PEO/PPO block copolymers are a good 
alternative. Recently, polypseudorotaxanes made of a normal Tetronic (T908) and α-CD 
have been used to prepare syringeable viscoelastic gels. Besides a good compatibility, 
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these materials combined with simvastatin showed an intrinsic ability to promote 
osteoblast differentiation.31 
In the present study, an in situ hydrogel prepared using α-CD and the reverse 
Tetronic 90R4 (90R4) was evaluated as a drug delivery device. The model molecules 
released from these gels were an aminoacid, L-Tryptophan (Trp), and a protein, bovine 
serum albumin (BSA). The 90R4/CD gels have proved to be erodible matrices, so they 
seem to be promising as drug release devices.20 The release of Trp and BSA from these 
90R4/CD matrices was evaluated using 90R4/CD hydrogels, and also with tablets made 
from these hydrogels. Different mathematical models were used in order to elucidate the 
mechanisms that predominate in the release processes from the tablets. 
 
EXPERIMENTAL 
Materials. Tetronic 90R4 (Mw= 6900 g/mol) was kindly donated by BASF and it was 
used as received. This poloxamine is a yellow liquid (viscosity 3870 cP at 25ºC). The 
composition of the four blocks in the polymer, determined by 1H-NMR (Bruker DPX 
300 at 298 K), is PO16EO18 per arm. α-CD was obtained from Wacker Chemie AG 
Cavamax® W6 Pharma Alfadex) and was used without further purifications. L-
Tryptophan (Trp) and Bovine serum albumin (BSA) were purchased from Sigma-
Aldrich and were used as received.  
 
Gel formation. All complexes were prepared by mixing a determinate amount of the 
90R4 poloxamine with an aqueous solution of α-CD followed by vigorous stirring. 
Before using them, the resulting mixtures were kept at room temperature for at least one 
night. Some of the gels were loaded with Trp or BSA in order to perform release 
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studies. These substances were previously dissolved in the α-CD solution before mixing 
it with the poloxamine. 
 
Tablet preparation. The resulting gels were freeze dried and the obtained product was 
compressed using a Specac pellet die. The resulting tablets were weighed and measured 
prior to their use (see Results and Discussion section). The hardness of the obtained 
samples was measured using a Caleva Tablet Hardness Tester (see Supporting 
Information for details). Freeze dried gels loaded with Trp or BSA were used to prepare 
tablets for release kinetics studies. Besides, additional tablets made from unloaded gels 
were used for the erosion kinetics analysis. Each BSA tablet contained 200 mg of the 
protein. On the other hand, the Trp tablets contained 30 mg of the amino-acid for the 
tablets prepared using 15% (w/w) of Tetronic and 20 mg of the amino acid for the 
tablets prepared using 25% (w/w). 
 
Tablet erosion studies. Seven unloaded tablets were placed into a SOTAX AT 7 Smart 
USP dissolution testing device at 37 ºC in 500 mL of pH 7 phosphate buffer medium; 
different experiments were performed using stirring speeds of 25 and 100 rpm. During 
the dissolution process, one tablet was removed from its vessel at different time 
intervals (see Supporting Information, Figure S1). These partially eroded tablets were 
placed in an oven at 37 ºC until constant weight. Using the initial weight of the tablet 
(W0) and the weight after been eroded (W1), the percentage of erosion at each time was 
calculated with the following equation (Eq 1): 
100 x Erosion %
0
10
W
WW −=   (1) 
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In vitro release kinetics. The release studies were also performed from 500 mL of pH 7 
phosphate buffer solutions using a SOTAX AT 7 Smart USP dissolution testing device 
at 37ºC at 25 rpm or 100 rpm stirring speeds. Samples (5 mL) were withdrawn 
according to a sampling time program of about 10 h, and these sample volumes were 
replaced with fresh medium. Trp (or BSA) concentrations in each sample were 
evaluated by UV-vis (Hewlett Packard 8452A) and fluorescence spectrophotometries 
(Perkin Elmer LS 50 B). Both the poloxamine and the substrate (BSA or Trp) absorb in 
the same UV region. On the other hand, the fluorescence of Trp (or BSA) is quenched 
by the poloxamine that is also released as the matrices are eroded. A combination of the 
results obtained from these two techniques had to be used in order to determine the 
amount of substrate released as a function of time (see Supporting Information for more 
details). In addition, it was verified that α-CD, which is also present in the solution 
during the erosion process, is not a quencher of Trp. The amount of α-CD released from 
the matrix was also evaluated, using size exclusion chromathography (SEC) (Waters 
600E with a Waters 2414 Refractive Index detector and an Aquagel OH-30 column). 
The mobile phase was deionized water and the flow rate was 1 mL/min. The obtained 
value for the area under the curve for the samples was compared to standard solutions to 
obtain the concentration of α-CD. Different release experiments were carried out using 
gels and tablets. In order to study the release kinetics from the gels, they were formed at 
the bottom of the dissolution testing device vessels and the dissolution medium was 
added on top of them at the beginning of the release kinetics. An amount of 20 g of gel 
was used in each experiment. For the tablets, the standard measuring method was used: 
the tablets were added into the vessels filled with the buffer media in order to start the 
release kinetic analyses. The experiments were performed in duplicate for the gels and 
in quadruplicate for the tablets.  
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 Analysis of release data. Different parameters were calculated with the release data 
obtained from gels and tablets. The mean dissolution time (MDT) can be calculated 
using the following equation (Eq 2). 
∑
∑
=
= Δ= n
j j
j
n
j j
M
Mt
MDT
1
1
·ˆ
  (2) 
where j is the sample number, n is the number of dissolution sample times, is the time 
at the midpoint between t
jtˆ
j and tj-1 and ΔMj is the additional amount of drug dissolved 
between tj and tj-1. 
 
The dissolution efficiency (DE) of a pharmaceutical dosage form is defined by the 
percentage of area under the dissolution curve up to a certain time t expressed as a 
percentage of the area of the rectangle described by 100% dissolution (y100) in the same 
time (Eq 3).26 
100
100
0 ××
×
=
∫
ty
dty
DE
t
  (3) 
In order to compare different release curves, the difference (f1) and similarity factor (f2) 
were calculated.26 
The difference factor (f1) (Eq. 4) calculates the percent (%) difference between the two 
curves at each time point and is a measurement of the relative error between the two 
curves: where n is the number of time points, R is the dissolution value of the reference 
t (prechange) batch at time t, and T is the dissolution value of the test (postchange) 
batch at time t. 
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The similarity factor (f2) (Eq. 5) is a logarithmic transformation of the sum-squared 
error of differences between the test Tj and reference products Rj over all time points, n. 
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The data obtained from the in vitro release experiments were fitted to different 
mathematical models of drug release. Several mechanisms are involved in drug release 
from hydrogel matrix systems: diffusion, swelling, and polymer erosion being the most 
important ones. Different mathematical models have been proposed to obtain 
information of the mechanisms, since it is difficult to develop a general expression 
suitable for every drug device. The most interesting models are the empirical/semi-
empirical ones, which provide an accurate fit to the experimental profiles (such as the 
Peppas equation and the Hopfenberg model), and the mechanistic realistic models, 
which give some insight into the real phenomena (such as those based on Fick’s law).33 
The models used for this study were the Korsmeyer-Peppas equation (Eq. 6), the 
Higuchi equation (Eq. 7), the Peppas-Sahlin equations (Eq. 8a), the zero-order equation 
(Eq. 9a), the first-order equation (Eq.10) and the Hopfenberg equation (Eq. 11). 
 
The Korsmeyer-Peppas model27 is a simple semiempirical model which exponentially 
relates drug release with the elapsed time (Eq. 6). 
n·tk KP
t
M
M =
∞
  (6) 
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where Mt/M∞ is the drug release fraction at time t, kKP is a constant incorporating the 
structural and geometric characteristics of the matrix tablets, and n is the release 
exponent indicative of the drug release mechanism. The value of n indicates the 
mechanism of the release.27 If the value is around 0.5 (the exact value depends of the 
geometry) the mechanism is Case I (Fickian) diffusion and a value between 0.5 and 
0.89 indicates anomalous (non-Fickian) diffusion. Values of n equal to 0.89 indicate 
Case II transport. 
0.5·tk H
t
M
M =
∞
  (7) 
If the obtained release mechanism is mainly a Fickian diffusion, a dimensionless 
expression of the Higuchi model was used26 (Eq. 7). Mt/M∞ is the drug release fraction 
at time t, and kH is the Higuchi constant. In the original Higuchi equation the Mt (amount 
of drug released at time t) term is found instead of Mt/M∞. 
 
The contribution of Fickian and non-Fickian release can be evaluated by using the 
Peppas-Sahling model equation28 (Eq. 8a). 
2m
E
m
D ·tk·tk +=
∞M
M t   (8a) 
where Mt/M∞ is the drug release fraction at time t, the first term of the right-hand side is 
the Fickian contribution (kD is the diffusional constant) and the second term is the Case 
II erosional contribution (kE is the erosional constant). m is the release exponent of 
purely Fickian diffusion. The value of m for our tablets was 0.43 as determined from the 
plot of aspect ratio (diameter/thickness) against diffusional exponent.29 The kD and kE 
values were used to calculate the contribution percentage of diffusion (D) and erosion 
(E) respectively with Eqs. 8b and 8c.29 
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The zero-order kinetics equation (Eq 9a) was also used in order to evaluate the type of 
release mechanism. This model is used for systems where the matrix releases the same 
amount of drug by unit of time.26 
·tk O0 Zt QQ +=   (9a) 
where Qt is the amount of drug dissolved in time t and Q0 is the initial amount of drug in 
the solution (most times, Q0 = 0) and KZO is the zero order release constant. We have 
used a modified zero-order equation (Eq. 9b), where we have replaced the Qt term with 
Mt/M∞. 
·tk OZ
t
M
M =
∞
  (9b) 
The first-order kinetics equation (Eq. 10) is shown below and describes the release of a 
drug in a way that is proportional to the amount of drug remaining in the interior of the 
matrix.26 
·tkln O
0
F
t
Q
Q =   (10) 
where Qt is the amount of drug dissolved in time t and Q0 is the initial amount of drug 
and kFO is the first order release constant. 
 
The evaluated tablets are eroded throughout the drug release process so a model that 
considers changes in the surface area of the matrix was used: a variation of the 
Hopfenberg model for tablets (Eq. 11).30  
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Where Mt/M∞ is the drug release fraction at time t, C0 is the initial concentration of drug 
in the tablet, a0 and b0 are the initial radius and thickness, respectively, and kHP is the 
erosion rate constant. 
 
In order to fit the experimental data to the previous equations, only one portion of the 
release profile was used, i.e. Mt/M∞ ≤ 0.8. In the literature, only the portion 
corresponding to Mt/M∞ ≤ 0.6 is used to study the applicability of the Korsmeyer-
Peppas equation.27, 29, 31 Nevertheless, we have used a wider range in this study because 
we found an excellent fitting up to a higher value of Mt/M∞. 
 
RESULTS AND DISCUSSION 
Release from gels. Gels prepared with Tetronic 90R4 and aqueous α-CD have been 
evaluated as release systems. These mixtures exhibit a pseudoplastic behaviour, i.e. the 
viscosity of the samples decreases when the shear rate is increased, and show an 
appropriate consistency.20 Two different types of 90R4/α-CD gels were evaluated, 
namely T25a10 and T15a10 (Table 1).  
 
Figure 1 shows the release of BSA and Trp from T25a10 and T15a10 as a function of 
time at 37ºC in a pH 7 aqueous medium. The release process of BSA and Trp from 
T25a10 is faster than that of T15a10. This is consistent with the gel erosion studies 
performed by our group in a previous work.20 Despite the significant differences in the 
amounts loaded and in the molecular sizes of both substrates, the release processes seem 
to be equivalent in both cases. In addition, the release of α-CD from the gels can be used 
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as an indicator of the erosion kinetics of the matrix, because α-CD is one of the 
components of the gel structure.  
The comparison between the release of α-CD and BSA is shown in Figure 2. As can be 
seen, both profiles, i.e. those of the released molecule (BSA) and the ones related to the 
gel structure (α-CD), match each other. This indicates that the release of substances 
from these gels is dominated by the erosion of the gel matrix. 
Table 2 shows the dissolution parameters calculated from the erosion curves for all 
these gels. Both the t50% and the mean dissolution time (MDT) values corresponding to 
T15a10 gels are always higher than those of T25a10, what indicates a faster release 
from the latter. The dissolution efficiency (DE) is slightly higher for T25a10 gels; this 
also indicates that the release is faster for these gels. These quantitative results confirm 
that the release of BSA can be considered comparable to the release of Trp from the 
same gel matrix. 
 
Table S1 (Supporting Information) shows the f1/f2 comparison factors for the release of 
BSA, Trp and α-CD. As can be seen all values of the f1 factors are lower than 15 and the 
values of f2 are higher than 50.  Therefore in both types of gel the release curves of 
BSA, Trp and α-CD can be considered equivalent. 
 
Release from tablets. In order to investigate the mechanism of release from Tetronic 
90R4 matrices, a controlled geometry was needed that allows us to apply different 
mathematical models. Cylindrical tablets were prepared by compressing freeze dried 
gels. Table 3 shows the size measurements and the composition of the tablets prepared 
in such a way.  
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Tablet erosion studies were carried out in order to compare these results with the release 
of α-CD from the tablet matrices (Figure 3). The release profile for α-CD in T15a10 
tablets and its erosion profile obtained by weighing the tablets as a function of time (see 
Experimental Part) are the same (Figure 3a). Nevertheless, the release profile of α-CD 
from a BSA loaded T15a10 tablet is slightly faster than the erosion profile of the void 
tablets (Figure 3b). This can be due to fact that the protein molecules cause some 
disruption in the structure of the matrix. Small differences between the profiles can also 
be also seen in the case of the T15a10-100 tablets, so the rotation speed influences the 
release process of α-CD (Figure 3c). The erosion process is clearly faster when the 
stirring speed is 100 rpm instead of 25 rpm. Nevertheless, the differences in these 
profiles are not very significant and the tablet erosion and the α-CD release profiles can 
be considered equivalent in all these cases.  
 
The f1/f2 comparison factors for the release of α-CD and the erosion curves for the 
tablets can be seen in Table S2 (Supporting Information). As can be seen all values of 
the f1 factors are lower than 15 and the values of f2 are higher than 50.  Therefore the 
erosion and α-CD release curves can be considered equivalent. Thus, the release of α-
CD, being a component of the matrices, can be used as an indicator of the tablet erosion. 
It has to be added that these erosion studies were not carried out for T25a10 tablets 
because they were too soft and difficult to handle when removed from the bath, in order 
to be dried and weighed. 
 
Figures 4a and 4b show the release of Trp and α-CD from T15a10 and T25a10 tablets. It 
is has to noticed that the differences in the profiles of Trp and α-CD means that the two 
release processes do not occur simultaneously as in the case of gels. Another 
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observation is that a tablet (ca. 1g) shows a sustained release for a time as long as that of 
a gel (20 g). The release of Trp from T25a10 seems to be faster than that of T15a10, but 
it is important to notice that the total amount of Trp loaded in T25a10 is near half the 
amount of Trp in the T15a10 tablets. Despite having practically the same release 
profiles, T15a10 tablets are preferred because they use less amount of Tetronic 90R4 
and they are more consistent. The dissolution parameters for the release of Trp from 
T15a10 and T25a10 tablets can be observed in Table 2. The lower values of MDT for 
the release of α-CD and Trp from T25a10 indicate that the release process from these 
tablets is slightly faster than that of T15a10 tablets. Both types of tablets show similar 
DE values in the release of the substances (ca. 70%). This is consistent with the value of 
f1 (lower than 15) and f2 (higher than 50) for these curves (see Supporting Information, 
Table S2) indicates that there is no difference between them. In addition f1 and f2 values 
for the release of α-CD from T25a10 and T15a10 (Table S2) gels points that they can be 
considered equivalent too. 
 
Figure 4c shows the release of Trp from T15a10-100 (i.e. T15a10 tablets stirred at 100 
rpm instead of 25 rpm). As expected, the release of α-CD and Trp is faster than the 
release process at 25 rpm (Figure 4b). This is quantitatively confirmed in Table 2, 
where the dissolution parameters for both substances are displayed. In addition, Table 
S2 shows f1 and f2 factors which suggest that there are differences between the release 
curves of Trp and α-CD using 25 and 100 rpm for the study. 
 
The release process for BSA from T15a10 tablets is shown in Figure 4d. The BSA 
protein is a considerably larger molecule, so its release is slightly slower because it 
needs more time to leave the matrix. It is important to notice that the amount of BSA 
 15
loaded in the T15a10 tablet is much higher than that of Trp (200 vs. 30 mg). As pointed 
above, the release of α-CD from BSA loaded tablets is practically equivalent to its 
release from Trp tablets. In BSA loaded tablets, the release of α-CD is faster than the 
release of BSA, suggesting that BSA remains in the tablet with the poloxamine 
molecules while α-CD is released. As can be seen in the dissolution parameters 
comparison (Table 2), the MDT for BSA release (ca. 180 min) is significantly higher 
than the Trp values, indicative of a slower release. In contrast, for BSA loaded tablets, 
the release of α-CD is faster (i.e. lower MDT and t50%) than that of Trp loaded tablets. In 
contrast the f1 and f2 values calculated for the BSA and Trp release indicates that these 
release curves can be considered as equivalent. The f1 and f2 values obtained for the 
comparison between the α-CD release from BSA and Trp loaded tablets are not 
conclusive because f1 is lower than 15 but the f2 is lower than 50.  
One last type of T15a10 tablets was prepared, using a rotary evaporator to dry out the 
gels instead of freeze drying them (T15a10-R). The release of Trp from these tablets is 
slower than the release from the freeze dried ones (Figure 5). This can be due to the 
more compact structure of the dried gel leading to a slower dissolution process. In fact, 
the calculated MDT value (Table 2) was the highest of all the studied tablets.  
 
All the release profiles were fitted to different mathematical release models (Table 4). 
The results for the Korsmeyer-Peppas equation show that the release mechanism of Trp 
molecules could be diffusion, because of the values found for the n parameter (ca. 0.5). 
On the other hand, the n values obtained for the release of BSA and α-CD from the 
different types of gels point to the fact that their release mechanism could be a 
combination of erosion and diffusion (values between 0.5 and 1). The values of the kKP 
are quite similar for all the Trp profiles with the exception of T15a10-100, which is 
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higher, and T15a10-R, which is lower. The release process is faster for T15a10-100 due 
to the high stirring speed, and it is slower for T15a10-R due to the different nature of 
the tablet. The fitting results are good for all the tablets as the higher values of R2 
parameter indicate. 
 
The Higuchi equation was used in order to achieve a better fit for the releases governed 
by a mechanism of diffusion. For this equation, good R2 values were obtained for all the 
Trp releases. The α-CD release profiles present poorer values for R2, clearly showing 
that the release mechanism is not governed by diffusion. In contrast, the release of BSA 
shows a better fit to the Higuchi model than those of α-CD because of its lower value of 
n in the Korsmeyer-Peppas equation. 
 
The first and zero-order equations do not show good values of R2. The best values 
correspond to those of zero-order equation for the release of α-CD. In accordance with 
the n values in the Korsmeyer-Peppas for the release of α-CD (above 0.5), the fittings to 
the zero-order are better than the Higuchi fittings.  
 
In order to evaluate the relative influence of diffusion and erosion in the release 
mechanisms, all the profiles were fitted to the Peppas-Sahlin equation. Two constant 
were obtained, kD and kE, for the diffusion and for the erosion processes, respectively. 
The high values of R2 (ca. 1) show that very good fittings have been obtained in all 
cases. The values of the diffusional constants were higher for the releases of Trp, while 
the erosional constants were higher for the release of α-CD. The release of BSA from 
T15a10 shows a higher erosion constant than that of Trp from the same tablets but the 
diffusional constant is higher in the second case, which indicates that the contribution of 
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erosion is higher in the release mechanism of a big molecule. Using equations 6b and 
6c, the percentage contribution of the erosional and diffusional mechanisms can be 
graphically seen. In all the Trp releases, the main mechanism is diffusion along the 
whole release process (see Supporting Information, Figure S2). On the other hand, the 
release of α-CD in all the tablets is mainly dominated by erosion (Figure S3).  
 
The release of BSA is a special case (Figure 6), because it starts dominated by diffusion 
but, after 5 hours, the erosion predominates in the process. A possible explanation for 
this phenomenon is that, during the first part of the release process, the BSA molecules 
that are located in the external parts of the tablet can diffuse easily. Once these 
molecules have been released, the BSA molecules in the interior can not diffuse that 
fast, so the tablet must be eroded in order to deliver the rest. It has to be added that, as 
occurs with other surfactants 32, BSA is also partially denatured by these amphiphilic 
block copolymers. This fact became evident when the quenching of the BSA 
fluorescence was studied in order to quantify the amount of BSA released. It was found 
that the poloxamine molecules that come into the solution when the matrix is eroded are 
responsible for an attenuation in the fluorescence of the protein. This quenching process 
corresponds to that of a denatured BSA (see Supporting Information, Figure S4) 33. The 
reversibility of a possible denaturation process caused by the constituents of the 
delivery matrix will be obviously an important concern when a protein is the substrate 
in these devices. 
 
Finally, the last model tested was the Hopfenberg equation. This is an erosion model, so 
the best values of R2 are obtained for the release of α-CD, as it could be expected. Thus, 
we can conclude that the main mechanism for the release of α-CD is the erosion. The 
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release of Trp does not present good values for the R2 parameter. The main mechanism 
for the release of Trp is not the erosion of the matrix. Fickian diffusion is more 
important in this case, as can be seen in the results for the Korsmeyer-Peppas and 
Higuchi equations. Interestingly, the release of BSA is an intermediate case. On the one 
hand, it shows a good fit to the Hopfenberg equation (although not as good as that of α-
CD) and, in the other hand, the Peppas-Sahlin equation shows that the release 
mechanism is a combination of Fickian diffusion and erosion. 
 
CONCLUSIONS 
Two different types of 90R4/α-CD matrices were evaluated as potentially drug delivery 
systems, namely gels and tablets. While 90R4/α-CD gels seem to be good sustained 
delivery devices, the amount of gel needed could be excessive for some applications. 
Nevertheless, this could be a promising delivery device for transdermal devices. On the 
other hand, tablets made by compression of freeze dried 90R4/α-CD gels release the 
tested substances in an appropriate fashion using smaller amounts of matrix than the 
parent gels. 
 
Different drug release mathematical equations were applied to the release profiles of the 
tablets. After analyzing the results, we can conclude that the release process can be 
tailored by controlling parameters such as the matrix composition, the stirring speed in 
the release assay, the nature of the molecule to be released or the gel drying process. 
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Tablet preparation 
The tablets can be easily prepared using a Specac evacuable pellet die: the required 
amount of lyophilized gel (ca. 1 g) is placed using two polyethylene discs as spacers (to 
avoid sticking) between the plunger and the die stainless steel pellet (13 mm diameter). 
Handling it with care, a Perkin Elmer hydraulic press can be used to compress the 
tablets, provided that a minimal pressure is applied to avoid loss of gel by leaking. 
Nevertheless, a better procedure can be described as follows: a load of ca. 2 kg (i.e. 
about 15 N·cm-2 or 1.5 atm) is applied during five minutes. The obtained tablet is 
carefully removed from the die and the resulting dimensions and weight are measured. 
No lubricants were needed. It was observed that an excess load of 3 kg (or a pressure of 
23 N·cm-2) caused a leaking of the gel in the case of T25a10 sample.  
The average hardness values of the two types of tablets were 6.5±0.9 N for 
T25a10 and 10.8±1.8 N for T15a10. 
 
 
 
 
Figure S1. Photograph of T15a10 eroded tablets at different times. 
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Determination of released amounts of Trp or BSA 
In order to quantify the release amounts of both active ingredients (either Trp or BSA) 
the procedure consisted on combining their fluorescence signals, quenched by Tetronic 
90R4, with the UV-vis signal, which is the addition of both, the active ingredient and 
the Tetronic contributions. Three calibration curves are needed: 
(a) Fluorescence:  If  = Kf(Active)·[Active] 
(b) UV-vis:   A(Active) = KUV(Active)·[Active] 
A(90R4) = KUV(90R4)·[90R4] 
The samples collected by the dissolution testing device were evaluated both by UV-vis 
at 280 nm and by fluorescence emission at 341 nm (excitation at 280 nm). With these 
data, the following equations are obtained: 
 UV-vis:   Asample = KUV(Active)·[Active] + KUV(90R4)·[90R4] 
 Fluorescence:  If/IQ = KQ·[90R4]  ?   IQ = If/(KQ·[90R4]) 
where KQ is the quenching Stern-Volmer constant at room temperature and IQ is the 
actual intensity measured for each sample and If would be that in the absence of the 
quencher, i.e. the one we have in the calibration curve. 
 Using the constants from the UV-vis calibration curves (KUV(Active) and KUV(90R4)) 
and, in the case of the fluorescence signal expression, substituting If  from its 
calibration, we obtain two equations with two unknowns ([Active] and [90R4]): 
 
UV-vis:   Asample = KUV(Active)·[Active] + KUV(90R4)·[90R4] 
Fluorescence: IQ = (Kf(Active)·[Active])/(KQ·[90R4]) 
 
These procedure yields excellent results for [Active], i.e. either Trp or BSa 
concentrations. In the case of [90R4] the results are poorer because its molar 
absorptivity is considerably smaller, so the errors are higher. 
 
 
 28
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600
t (min)
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600
t (min)
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600
t (min)
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600
t (min)
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
(a)
(c)
(b)
(d)
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
P
er
ce
nt
ag
e 
co
nt
rib
ut
io
n
 
Figure S2.  The percentage contribution of the diffusion (●) and the erosion (○) mechanisms for 
the TRP release from T25a10 (a), T15a10 (b), T15a10-100 (c) and T15a10-R (d).  
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Figure S3.  The percentage contribution of the diffusion (●) and the erosion (○) mechanisms for 
the α-CD release from T25a10 (a), T15a10 (Trp loaded tablet) (b), T15a10-100 (c) and T15a10 
(BSA loaded tablet) (d). 
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Figure S4. Stern-Volmer quenching plots for BSA with two different quenchers: Tetronic 90R4 
(a) and  I- (b). For the native protein, only one of its two tryptophans (Trpa and Trpb) is 
accessible to iodide quenching, and a nonlinear Stern-Volmer plot is obtained.  In the first plot, 
a linear fit would indicate that both Trp residues are accessible to the quencher, i.e. the native 
conformation has been lost. 
 
 
Table S1.  f1 and f2 comparison factors for BSA, Trp and α-CD release curves from Tetronic/α-
CD  gels. 
Curve 1 Curve 2 f1 f2
T25a10 BSA release T25a10 Trp release 7.5 51.9 
T15a10 BSA release T15a10 Trp release 11.1 53.1 
BSA T25a10 α-CD release T25a10 BSA release 4.9 68.3 
BSA T15a10 α-CD release T15a10 BSA release 6.4 66.5 
Trp T25a10 α-CD release T25a10 BSA release 2.3 83.2 
Trp T15a10 α-CD release T15a10 BSA release 10.0 63.6 
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Table S2.  f1 and f2 comparison factors for erosion kinetics curves and α-CD and release curves 
from Tetronic/α-CD tablets. 
 
Curve 1 Curve 2 f1 f2
Erosion of T15a10 Trp T15a10 α-CD release 8.5 60.3 
Erosion of T15a10 BSA T15a10 α-CD release 12.4 51.9 
Erosion of T15a10-100 Trp T15a10-100 α-CD release 14.2 53.1 
Erosion of T15a10-R Trp T15a10-R α-CD release 43.8 24.9 
T25a10 Trp release T15a10 Trp release 6.8 58.8 
T15a10 Trp release T15a10-100 Trp release 17.6 40.2 
T15a10 BSA release T15a10 Trp release 11.6 53.1 
Trp T25a10 α-CD release Trp T15a10 α-CD release 11.4 50.3 
Trp T15a10 α-CD release Trp T15a10-100 α-CD release 27.1 32.6 
BSA T15a10 α-CD release Trp T15a10 α-CD release 14.4 46.2 
T15a10 Trp release T15a10-R Trp release 23.3 36.4 
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